Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Prevention of Overdose Deaths and Opioid Relapse Following Discharge: A Multi-Center RCT of Naltrexone Versus Buprenorphine in Norway

NCT01717963 is registered in ClinicalTrials.gov with University of Oslo as lead sponsor.

NCT NCT01717963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01717963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Prevention of Overdose Deaths and Opioid Relapse Following Discharge: A Multi-Center RCT of Naltrexone Versus Buprenorphine in Norway
Lead sponsor
University of Oslo
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2012
Completion date
April 30, 2018
Enrollment
166 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

opioid dependence